Apr 11, 2024
AIVITA Biomedical CEO Dr. Hans Keirstead and CMO Dr. Robert Dillman to Speak and Participate in Keynote Panel at Festival of Biologics USA
Apr 02, 2024
AIVITA Biomedical CEO Dr. Hans Keirstead to Join Keynote Panel for AI in Public Health at World Vaccine Congress
Feb 27, 2024
AIVITA Biomedical Strengthens Board of Directors with Appointment of Ex-Biogen CEO Michel Vounatsos
Dec 29, 2020
AIVITA Biomedical Closes $25 Million Financing Round
Aug 03, 2020
AIVITA Biomedical Publishes Review of GM-CSF History and Rationale as Vaccine Adjuvant in Melanoma Management
Feb 25, 2020
AIVITA Biomedical Raises $12.5 Million in Series B-2 Financing Round and Announces New Board of Directors Appointee
Feb 04, 2020
AIVITA Biomedical Completes Patient Recruitment in Phase 2 GBM Trial
Nov 12, 2019
AIVITA Biomedical Announces New Positive Phase 2 Glioblastoma Data at SITC Annual Meeting Podium Presentation
Nov 08, 2019
Brain Cancer Patient Survival, Immune and Tumor Data from AIVITA Biomedical's Phase 2 Clinical Trial to be Presented at SITC Annual Meeting
Nov 01, 2019
AIVITA Biomedical to Present at Upcoming Regenerative Medicine, Oncology and Investor Conferences in November
Oct 30, 2019
AIVITA Biomedical Announces Publication Detailing Immune Mechanisms Leading to Complete Remission of Measurable Metastatic Melanoma in Patient Treated with AIVITA Immunotherapy
Oct 02, 2019
AIVITA Biomedical Announces Publication Concerning a Predictive Biomarker for Melanoma Patients Treated with the Company's Platform Immunotherapy
Oct 01, 2019
AIVITA CEO Dr. Hans Keirstead Honored as One of Canada's 'Seven Wonderers' at Beakerhead Festival
Oct 01, 2019
AIVITA Biomedical to Present at Meeting on the Mesa and Other Investor, Oncology and Regenerative Medicine Conferences in October
Aug 01, 2019
AIVITA Biomedical Receives Import Approval to Distribute its Professional ROOT of SKIN(TM) MD Skincare Line in Japan
Mar 01, 2019
AIVITA Biomedical to Present Cancer Vaccine Data at 2019 ASCO-SITC Clinical Immuno-Oncology Symposium
Feb 21, 2019
AIVITA Completes Treatment of First Patient in Phase 2 Ovarian Cancer Trial
Oct 25, 2018
AIVITA Biomedical Enrolls First Patient in Phase 2 Glioblastoma Trial